Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-25-132712
Filing Date
2025-06-02
Accepted
2025-06-02 06:09:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC TO-C d924245dsctoc.htm SC TO-C 13910
2 EX-99.1 d924245dex991.htm EX-99.1 40781
3 GRAPHIC g924245dsp4.jpg GRAPHIC 1259
4 GRAPHIC g924245g0602103559655.jpg GRAPHIC 2601
5 GRAPHIC g924245g0602103559896.jpg GRAPHIC 3270
  Complete submission text file 0001193125-25-132712.txt   66807
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Subject) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88827 | Film No.: 251013038
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)